Abstract:Many bioactive peptides demonstrated therapeutic effects over complicated diseases, such as antiviral, antibacterial, anticancer, etc. It is possible to generate a large number of potentially bioactive peptides using deep learning in a manner analogous to the generation of de novo chemical compounds using the acquired bioactive peptides as a training set. Such generative techniques would be significant for drug development since peptides are much easier and cheaper to synthesize than compounds. Despite the limited availability of deep learning-based peptide-generating models, we have built an LSTM model (called LSTM_Pep) to generate de novo peptides and fine-tuned the model to generate de novo peptides with specific prospective therapeutic benefits. Remarkably, the Antimicrobial Peptide Database has been effectively utilized to generate various kinds of potential active de novo peptides. We proposed a pipeline for screening those generated peptides for a given target and used the main protease of SARS-COV-2 as a proof-of-concept. Moreover, we have developed a deep learning-based protein-peptide prediction model (DeepPep) for rapid screening of the generated peptides for the given targets. Together with the generating model, we have demonstrated that iteratively fine-tuning training, generating, and screening peptides for higher-predicted binding affinity peptides can be achieved. Our work sheds light on developing deep learning-based methods and pipelines to effectively generate and obtain bioactive peptides with a specific therapeutic effect and showcases how artificial intelligence can help discover de novo bioactive peptides that can bind to a particular target.

A Hybrid Diffusion Model for Stable, Affinity-Driven, Receptor-Aware Peptide Generation

A Unified Conditional Diffusion Framework for Dual Protein Targets Based Bioactive Molecule Generation

E(3)-invariant diffusion model for pocket-aware peptide generation

Hotspot-Driven Peptide Design via Multi-Fragment Autoregressive Extension

Complex-based Ligand-Binding Proteins Redesign by Equivariant Diffusion-based Generative Models

Recent Advances and Computational Approaches in Peptide Drug Discovery

Deep Learning-Based Bioactive Therapeutic Peptide Generation and Screening

De novo design of high-affinity binders of bioactive helical peptides

Design of Peptide Binders to Conformationally Diverse Targets with Contrastive Language Modeling

Full-Atom Peptide Design with Geometric Latent Diffusion

Deep generative models for peptide design

Peptide-based drug discovery through artificial intelligence: towards an autonomous design of therapeutic peptides

De Novo Design of Peptide Binders to Conformationally Diverse Targets with Contrastive Language Modeling

AMP-Diffusion: Integrating Latent Diffusion with Protein Language Models for Antimicrobial Peptide Generation

Hunting for peptide binders of specific targets with data-centric generative language models

Deep learning for advancing peptide drug development: Tools and methods in structure prediction and design

PepMLM: Target Sequence-Conditioned Generation of Therapeutic Peptide Binders via Span Masked Language Modeling

ProT-Diff: A Modularized and Efficient Approach to De Novo Generation of Antimicrobial Peptide Sequences through Integration of Protein Language Model and Diffusion Model

DeepREAL: A Deep Learning Powered Multi-scale Modeling Framework Towards Predicting Out-of-distribution Receptor Activity of Ligand Binding

PIDiff: Physics informed diffusion model for protein pocket-specific 3D molecular generation

A dual diffusion model enables 3D molecule generation and lead optimization based on target pockets